Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Patent
1994-06-16
1995-12-05
Dentz, Bernard
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
514249, 514258, 514301, 514302, 544184, 544255, 544278, 544350, 546114, 546115, 546116, A61K 31435, C07D49504, C07D51304, C07D491048
Patent
active
054729645
ABSTRACT:
Compounds having the formula I: ##STR1## are antagonists of the actions of leukotrienes. These compounds are useful as anti-asthmatic, anti-allergic, anti-inflammatory, and cytoprotective agents. They are also useful in treating angina, cerebral spasm, glomerular nephritis, hepatitis, endotoxemia, uveitis, and allograft rejection.
REFERENCES:
patent: 4794188 (1988-12-01), Musser et al.
patent: 4957932 (1990-09-01), Young et al.
Dufresne Claude
Gareau Yves
Labelle Marc
Lau Cheuk K.
Leblanc Yves
Dentz Bernard
Merck Frosst Canada Inc.
Rose David L.
Yang Mollie M.
LandOfFree
Diaryl 5,6-fused heterocyclic acids as leukotriene antagonists does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Diaryl 5,6-fused heterocyclic acids as leukotriene antagonists, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Diaryl 5,6-fused heterocyclic acids as leukotriene antagonists will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1374318